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Abstract. Agrin is an extracellular matrix (ECM) pro- 
tein with a calculated relative molecular mass of more 
than 200 kD that induces the aggregation of acetylcho- 
line receptors (AChRs) at the neuromuscular junction. 
This activity has been mapped to its COOH terminus. 
In an attempt to identify the functions of the NH2-ter- 
minal end, we have now characterized full-length chick 
agrin. We show that chick agrin encoded by a previ- 
ously described cDNA is not secreted from transfected 
cells. Secretion is achieved with a construct that in- 
cludes an additional 350 bp derived from the 5' end of 
chick agrin mRNA. Recombinant agrin is a heparan 
sulfate proteoglycan (HSPG) of more than 400 kD with 
glycosaminoglycan side chains attached only to the 
NH2-terminal half. Endogenous agrin in tissue homoge- 
nates also has an apparent molecular mass of >400 kD. 
While the amino acid sequence ncoded by the 350-bp 
extension has no homology to published rat agrin, it in- 
cludes a stretch of 15 amino acids that is 80% identical 
to a previously identified bovine HSPG. The extension 
is required for binding of agrin to ECM. AChR aggre- 
gates induced by recombinant agrin that includes the 
extension are considerably smaller than those induced 
by agrin fragments, uggesting that binding of agrin to 
ECM modulates the size of receptor clusters. In addi- 
tion, we found a site encoding seven amino acids at the 
NH2-terminal end of agrin that is alternatively spliced. 
While motor neurons express the splice variant with the 
seven amino acid long insert, muscle cells mainly syn- 
thesize isoforms that lack this insert. In conclusion, the 
cDNAs described here code for chick agrin that has all 
the characteristics previously allocated to endogenous 
agrin. 
p ROPER synaptic transmission requires a high degree of cell specialization at the site of contact between 
pre- and postsynaptic cells. The best studied chemi- 
cal synapse is the neuromuscular junction (NMJ), 1 where 
the nerve terminal of a motor neuron synapses on a mus- 
cle fiber. The ingrowing motor axon initiates in muscle fi- 
bers a local accumulation of several proteins of the cyto- 
sol, the cell membrane and the xtracellular matrix (ECM; 
for a review see Hall and Sanes, 1993). The formation of 
these specializations in the muscle fiber is triggered by 
molecules released from the nerve (Frank and Fischbach, 
1979; Dahm and Landmesser, 1991). The best-character- 
ized molecule known to be involved in this process is 
agrin. When added to cultured myotubes, agrin induces 
the aggregation f AChRs and other molecules concen- 
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trated at the NMJ (Nitkin et al., 1987; Wallace, 1989). This 
process is believed to be mediated by binding of agrin to 
specific signaling receptors on the muscle cell surface (for 
reviews ee Fallon and Hall, 1994; Bowe and Fallon, 1995). 
Active agrin is synthesized by motor neurons and is trans- 
ported to the nerve terminal where it is released and be- 
comes incorporated into the nascent muscle cell basal am- 
ina (reviewed by McMahan, 1990). Nevertheless, agrin is 
also found in nonsynaptic basal laminae of muscle, in kid- 
ney and capillaries (Reist et al., 1987; Fallon and Gelfman, 
1989; Godfrey, 1991; Rupp et al., 1991; Ruegg et al., 1992), 
suggesting that it may also have other functions. 
The molecular mass of agrin deduced from cDNAs in 
rat, chick, and the marine ray is more than 200 kD (Rupp 
et al., 1991; Tsim et al., 1992; Smith et al., 1992). However 
a COOH-terminal, 45-kD fragment of agrin is ufficient to 
induce AChR clustering on cultured myotubes with high 
efficacy (Gesemann et al., 1995). Within this active frag- 
ment, two sites (called A and B in chick and ray, y and z in 
rat) whose positions and amino acid sequences are con- 
served among the three species are subject o alternative 
mRNA splicing. When expressed in eukaryotic ells, only 
recombinant agrin isoforms with inserts at both sites are 
active in inducing AChR clusters, while those lacking in- 
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serts are much less or not at all active (Ruegg et al., 1992; 
Ferns et al., 1992, 1993; Gesemann et al., 1995). In vivo, 
transcripts encoding agrin isoforms are differentially dis- 
tributed. The most active ones are expressed by cholin- 
ergic neurons, such as motor neurons of the spinal cord 
and ciliary ganglia neurons, and the inactive ones are highly 
expressed by nonneuronal cells like myotubes and Schwann 
cells (Ruegg et al., 1992; McMahan et al., 1992; Hoch et al., 
1993; Thomas et al., 1993; Smith and O'Dowd, 1994; Ma et 
al., 1994, 1995). Thus, expression of specific isoforms is 
most likely the basis of the observed ifference between 
muscle cell-derived and motor neuron-derived agrin in in- 
ducing AChR aggregates (Reist et al., 1992; Cohen and 
Godfrey, 1992). 
As in other extracellular matrix proteins, agrin consists 
of several repeated regions. There are nine Kazal inhibi- 
tor-like domains that are also found in follistatin, six EGF- 
like domains, and three globular domains homologous to 
COOH-terminal domains of laminin a-chains. Homolo- 
gous domains in other ECM molecules have been impli- 
cated in particular functions, such as cell--cell recognition 
and growth factor binding, which has led to many propos- 
als for additional functions of agrin (e.g., Patthy and Ni- 
kolics, 1993). The NHz-terminal half of agrin also contains 
several potential sites for carbohydrate attachment. There 
are five potential N-glycosylation sites, two serine/threo- 
nine-rich regions, and at least six potential glycosami- 
noglycan (GAG) chain attachment sites. 
As a first step in searching for additional functions of 
agrin isoforms, we aimed to express full-length chick agrin 
and to characterize its biochemical properties in more de- 
tail. When we transfected COS-7 cells with the previously 
described agrin cDNA (Tsim et al., 1992) the recombinant 
protein was not targeted to the ER and hence, was not se- 
creted from the cells. Here we present achick agrin cDNA, 
whose coding sequence at the 5' end is extended by ~350 
bp. Agrin with this extension is secreted from transfected 
cells. The new sequence includes a stretch of 15 amino ac- 
ids that is highly homologous to a peptide previously char- 
acterized in a heparan sulfate proteoglycan (HSPG) of bo- 
vine kidney (Hagen et al., 1993). Only recombinant agrin 
that includes this extension binds to Matrigel TM, a solubi- 
lized mixture of ECM components. Recombinant chick 
agrin, depending on the inserts at site A and B, is active in 
inducing AChR aggregates on cultured myotubes. How- 
ever, AChR clusters are considerably smaller than those 
induced by fragments of agrin. In addition, we have found 
a new 21-bp-long site at the 5' end that is alternatively 
spliced. At early stages of synaptogenesis, motor neurons 
synthesize agrin mRNA with the 21-bp-long insert and the 
majority of agrin transcripts expressed in muscle lack this 
insert. In conclusion, these 5' extended constructs code for 
chick agrin isoforms that appear to fulfill all criteria to be 
full-length. 
Materials and Methods 
Polymerase Chain Reaction 
Conditions for PCR were as described elsewhere (G semann etal., 1995). 
Numbering of oligonucleotides is according to the sequences published by 
Tsim et al. (I992). Oligonucleotides of new 5' sequences are negatively 
numbered. All PCR products used to generate xpression constructs were 
cloned into PCR II cloning vector (lnvitrogen, San Diego, CA) and se- 
quenced to ensure that no mutations were introduced by DNA amplifica- 
tion. 
mRNA Isolation, Reverse Transcription and PCR 
Poly A + RNA was isolated with the Micro-FastTrack mRNA Isolation 
Kit (Invitrogen) according to the manufacturer's advice. RACE experi- 
ments (Frohmann et al., 1988; Loh et al., 1989) were performed with the 5' 
RACE System (GIBCO BRL, Gaithersburg, MD) according to the manu- 
facturer's advice. The oligonucleotide used for the reverse transcription 
reaction was as366 (CGTTGCTGTAGGTGGAATA) and the oligonu- 
cleotide as232 (ATCCCTCGGCAGGCATCTCG) served as primer in 
the subsequent PCR reaction. Reverse transcriptase-polymerase chain re- 
action was conducted as described in Ruegg et al. (1992) except hat Su- 
perscript TM II reverse transcriptase (GIBCO BRL) was used. To construct 
cDNAs encoding complete agrin isoforms, first strand synthesis was 
primed with as366 and subsequent PCR was conducted using EcoRl_s- 
289 (GCATAGAATrCGGCTGCGGGCGATGGG) as the sense primer 
and as232 as the antisense primer (see also below). 
Chicken Genomic Library Screening 
A chicken genomic library from adult chicken liver (Clontech, Palo Alto, 
CA) was screened according to the manufacturer's advice. Recombinant 
phage (~9 x 105) from the amplified EMBL-3 library were screened with 
32p-labeled DNA probe (nucleotides 134 to 547; for location see Fig. 3). 
Hybridization was at 42°C in 5× SSC, 0.1% SDS, 5x Denhardt's reagent, 
30% formamide, and 0.1 mg/ml salmon sperm DNA. Filters were washed 
at a maximal stringency of 0.2× SSC, 0.1% SDS at 65°C. Two rounds of 
dilution were applied for cloning. DNA of positive recombinant phage 
was prepared as follows: 450 ml of 50 mM Tris-HC1, pH 7.5, 10 mM NaCI, 
8 mM MgSO4, 0.01% gelatin were inoculated with a single positive 
plaque. 60 ~1 of maltose-induced NM-538 (Sambrook et al., 1989) in 10 
mM MgSO 4 (OD600 = 2) were added and incubated for 15 min at 37°C. 
After adding 30 ml of growth medium, 10 mM MgSO4, cells were incu- 
bated at 37°C until lysis. 300 t~1 chloroform were added and incubation 
was continued for another 45 min. The lysate was centrifuged for 15 min 
at 15,000 g to pellet cell debris. The supernatant was incubated with ap- 
proximately 100 p.g DNase (Boehringer Mannheim, Mannheim, Ger- 
many) and 100 ~g RNase (Boehringer Mannheim) for 1 h at 37°C. 7 ml of 
20% PEG (6,000) in 2.5 M NaCI were added and incubation was contin- 
ued for 1 h on ice. After centrifugation for 15 min at 13,000 g, the pellet 
was dissolved in 450 /~1 10 mM Tris-HCl, pH 8.0, 0.5% SDS, 10 mM 
EDTA, 10 mM NaCI and 20 ~g proteinase K (Boehringer Mannheim). 
Digestion was performed for 30 min at 60°C. After phenol/chloroform ex- 
traction, DNA was precipitated with ethanol. Inserts were excised by SalI 
digestion, analyzed on agarose gel, and subcloned into Bluescript KS 
(Stratagene, La Jolla, CA). 
Alternative mRNA Splicing 
To examine the relative abundance of agrin mRNA, randomly primed 
cDNAs were subjected to PCR using either primers s86 (CCCACCG- 
CAACGAGCTGATG) and as232, which flank the novel splice site, or 
primers s5377 (TTTGATGGTAGGACGTACATG) and as5511 (CT- 
TCTGTT/TGATGCTCAGC),  which flank the B site. PCR reaction was 
performed in 50 ~l containing 10% of reverse transcription mixture and 3 
× 105 cpm of 32p-end labeled oligonucleotide as232 or s5377 (Sambrook et 
al., 1989). After 30 rounds of amplification (94°C, 1 min; 56°C, 2 min; 72°C, 
2 min; final extension step of 10 min), 30% of the reaction mixture was 
fractionated by electrophoresis on a 8% polyacrylamide gel. The relative 
amount of each PCR product was determined by analysis on a Phosphor- 
Imager (Molecular Dynamics, Sunnyvale, CA). 
Expression Constructs 
To distinguish expression constructs from recombinant protein, cDNA 
constructs are named with the prefix p followed by the name of the pro- 
tein they encode. All partial chick agrin cDNA constructs, with the excep- 
tion of pcFull ps, pcNFull ps, pcNAgrin, and pcAgrin (see below), contain 
the ER signal sequence of hemagglutinin of the avian influenza virus de- 
scribed by Tsim et al. (1992). 
cDNA constructs encoding the NH2-terminal part of chick agrin wei'e 
made as follows: for future use a myc epitope (Evan et al., 1985) was in- 
serted at the COOH terminus of chick agrin. This was achieved by PCR 
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using s5377 as the sense primer (TTTGATGGTAGGACGTACATG),  
as5945 myc XbaI as the antisense primer (GGCCCTCTAGAACTAAT- 
TCAAGTCCTCCTCGCTGATTAACTITFGTTCTITGGCTA/GG/A-  
CAGTGTAATA) and pC95AOB0 as template. The gel-purified PCR prod- 
uct was cleaved with endonucleases Sail and Xbal and inserted into 
pcDNA I (Invitrogen) to obtain pMyc. To fuse these sequences to the 
NH2-terminal part of cFull hs, a BamHI restriction site was introduced at 5' 
end of the myc epitope: PCR was performed with pMyc as template, 
BamHI_myc as sense primer (CGACTGGATCCAAGAACAAAAGT-  
TAAT) and SP6 as the antisense primer (CATI 'TAGGTGACAC- 
TATAG). After digestion of the resulting PCR product with restriction 
endonucleases BamHI and XbaI, the BamHl/XbaI fragment from pc- 
Full h~ was replaced by the PCR product, yielding pcNFull hS. The analo- 
gous NH2-terminal construct (pcNFull~) containing the putative ER sig- 
nal sequence as proposed by Tsim et al. (1992) was constructed by 
replacing the SalI/XhoI fragment of pcNFull hs with that of pcFull pS. 
Construction of complete chick agrin cDNA was accomplished by 
three cloning steps: PCR products encoding the 5' extension were excised 
from the PCR II cloning vector with endonucleases EcoRI and XhoI and 
subcloned into a modified pcDNA I vector lacking the BamHI restriction 
site. This construct was then fused to the region encoding the NH2-termi- 
nal half of agrin by digestion with XhoI and BamHI and subsequent liga- 
tion to the corresponding cDNA fragment of pcNFull. The constructs 
were named pcNAgrin0 (no 21-bp insert) and pcNAgrin7 (with 21-bp in- 
sert). In the last step, sequence for the COOH-terminal part of chick agrin 
was fused to pcNAgrin 0and pcNAgrin7 using BamHI and XbaI restriction 
sites. To generate complete chick agrin cDNAs with different A and B 
sites, the corresponding pcFull h~ constructs were used as parent constructs. 
Unless specifically stated, cDNA constructs used throughout this study 
contain inserts at the novel site and lack inserts at sites A and B 
(pcAgrin7AoB0)- 
Antibodies 
To raise polyclonal antisera gainst cFuUhSA4B19, the procedures described 
by Gesemann et al. (1995) were used. 
Tissue Culture and Transfections 
COS-7 cells (Gluzman, 1981) were cultured in DME (GIBCO BRL) sup- 
plemented with 10% newborn calf serum, 10 mM sodium pyruvate, 100 U/ 
ml penicillin, and 100 p.g/ml streptomycin (all from GIBCO BRL). COS-7 
cells were transiently transfected with the DEAE-dextran-based method 
described by Cullen (1987). Chick myotube cultures were prepared as de- 
scribed (Gesemann et al., 1995). 
Metabolic Labeling, Immunoprecipitation, 
and Deglycosylation 
Metabolic labeling of intracellular proteins and immunoprecipitation f l-
lowed by deglycosylation with endo-13-N-acetylglucosaminidase H (Bo hr- 
inger Mannheim) was essentially done as described by Wessels et al. 
(1991) with some minor modifications: cell lysis and immunoprecipitation 
was performed at 0.5 M NaCl in the presence of 1 mM PMSF, 1 ixg/ml 
pepstatin, 10 i~g/ml aprotinin, 1 ~g/ml antipain, 1 p.g/ml leupeptin, and 1.75 
ixg/ml benzamidin. For immunoprecipitation, antiserum raised against 
cFnllhSA4B19 was used. Samples were analyzed by SDS-PAGE on a 4-10% 
gradient gel followed by fluorography. 
Immunoprecipitation of agrin in the conditioned medium was done as 
follows: 12 h after transfection, growth medium was replaced by 1 ml of 
labeling medium (25% DME, 65% MEM without methionine, 10% 
IgG-depleted FCS, 10 mM sodium pyruvate, 100 U/ml penicillin, 100 p~g/ 
ml streptomycin; all from GIBCO BRL), and 50 p.Ci/ml [35S]methionine. 
48-72 h after transfection, 0.5 ml of the conditioned medium was subjected 
to immunoprecipitation as described by Gesemann et al. (1995) using ei- 
ther antisera recognizing cFullhSA4BI 9 or  C95A4Bl 1. 
Heparansulfate glycosaminoglycan side chains were removed irectly 
after immunoprecipitation. The immunocomplex onprotein A-Sepharose 
beads was washed once with heparitinase incubation buffer (10 mM Tris- 
HCI pH 7.5, 50 mM sodium acetate, pH 7.5). 100 ill buffer and 0.05 U of 
Heparitinase (Sigma Chemical Co., St. Louis, MO) was added and incu- 
bated for 3 h at 37°C. Samples, released by adding 100 i~1 SDS-PAGE 
sample buffer and boiling, were then analyzed by SDS-PAGE on 3-12% 
gradient gel followed by fluorography. 
Immunoblot Analysis of Chick Tissues 
Tissues from Ell-E15 White Leghorn chick embryos were harvested and 
homogenized on ice with a 15 ml Dounce-homogenizer in the appropriate 
volume of PBS containing 1 mM PMSF, 1 ~g/ml pepstatin, 1 i~g/ml anti- 
pain, 10 p.g/ml aprotinin, 1 p.g/ml eupeptin, and 1.75 ~,g/ml benzamidin. 
Homogenized tissues were subjected to SDS-PAGE on a 3-12% gradient 
gel. Proteins (~100 p~g per lane) were transferred to nitrocellulose mem- 
branes (MiUipore, Marlborough, MA) according to Towbin et al. (1979) in 
the absence of methanol. The quality of protein transfer was tested by 
staining the membrane with Ponceau S (Serva, Heidelberg, Germany). 
Agrin-like immunoreactivity was visualized by the ECL method (Amer- 
sham, Buckinghamshire, UK). 
Enrichment of Motor Neurons 
Spinal cord segments were dissected from E5 White Leghorn chick em- 
bryos (developmental stages 26 and 27 according to the criteria of Ham- 
burger and Hamilton, 1951). After digestion with 0.1% trypsin in PBS 
containing 1% glucose for 30 rain at 37°C, the tissue was washed with 5 ml 
PBS supplemented with 300 U/ml DNase. A single cell suspension was ob- 
tained by gentle trituration. Cell debris were removed by centrifugation 
through a 3 ml cushion of 3.5% BSA in L-15, pH 7.4 for 15 min at 100 g. 
The cell pellet was resuspended in PBS, 0.5 mM EDTA. Motor neurons 
were enriched by density centrifugation on metrizamide (Dohrmann et 
al., 1986), by panning with mAb SC1 (Tanaka and Obata, 1984; Bloch- 
Gallego et al., 1991), or by metrizamide centrifugation followed by SC1 
panning. The panning of spinal cord cells on SCl-coated petri dishes 
(Bloch-Gallego et al., 1991) was slightly modified in the following way: 
100 mm polystyrene Petri dishes (Greiner, Ntirtingen, Germany) were 
coated with 10 ixg/ml purified IgG of mAb SC1 in 50 mM sodium carbon- 
ate buffer, pH 9.6. Dishes were washed twice with PBS and incubated with 
3% BSA in PBS for 1 h at room temperature. Cells were resuspended in 
MEM, 10% horse serum and incubated for 1 h at room temperature. The 
plates were washed four times with PBS with gentle swirling to remove 
nonadherent cells. Panned cells were lysed directly using the lysis buffer 
supplied by the Micro-FastTrack mRNA Isolation Kit. 
Immunocytochemistry 
Transiently transfected COS-7 cells were chilled to 4°C and anti-c95 anti- 
bodies (1:1,000) were incubated for 30 min at 4°C. After three washes with 
DME, cells were fixed for 30 rain at 4°C and 30 min at room temperature 
with 4% paraformaldehyde, 11% sucrose in 0.1 M potassium phosphate 
buffer, pH 7.2. After rinsing with PBS and 20 mM glycine in PBS, cells 
were permeabilized with 0.1% saponin in PBS (PBSS). 10 p.g/ml IgG of 
mAb 5B1 in PBSS + 10% normal goat serum (NGS) was incubated for 2 h. 
After four washes with PBSS, cells were incubated for 1 h with 
rhodamine-conjugated sheep anti-mouse IgG (1/200; Cappel, Durham, 
NC) and fluorescein-conjugated goat anti-rabbit IgG (1/200; Jackson Im- 
munoResearch Laboratories, Inc., West Grove, PA) in PBSS + 10% 
NGS. Cultures were washed with PBSS, mounted on glass cover slips with 
Vectashield TM (Vector Laboratories, Inc., Burlingame, CA), and exam- 
ined with fluorescence microscopy. 
Quantification ofA ChR Aggregation 
Incubation of cultured chick muscle cells with agrin, labeling of AChRs 
with rhodamine-conjugated a-bungarotoxin, and quantification of AChR 
clusters using an imaging system (Image-I/AT; Universal Imaging, West 
Chester, PA) was done as described by Gesemann et al. (1995). Due to 
the small size of AChR clusters induced by cAgrinTA4B 8 and cAgrin0AgB 8 
aggregates with the longer axis of ~2 p~m were included. Concentration of
recombinant agrin in conditioned medium of transfected COS cells was 
determined with an ELISA as described (Gesemann et al., 1995). 
Results 
The Coding Sequence of Agrin Is Extended 
at the 5' End 
To study properties of the entire chick agrin, the overlap- 
ping cDNAs isolated by Tsim et al. (1992) were fused. This 
cDNA construct is expected to encode full-length agrin, 
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Figure 1. Structure of chick 
agrin and of the constructs 
used in this study. Conserved 
sites for glycosaminoglycan 
side chain attachment and 
potential N-glycosylation are 
shown. Positions, designation 
and protein sequence of al- 
ternatively spliced inserts are 
given. On the right of each 
construct, he name and the 
isoforms used in this study 
are indicated. For future use, 
a myc-tag (Evan et al., 1985) 
was engineered tothe COOH 
terminus of some constructs. 
which we called cFull ps (for chick full-length with putative 
signal sequence; Fig. 1). COS-7 cells were transiently 
transfected with this cDNA construct to obtain recombi- 
nant protein. The presence of cFull ps in the conditioned 
medium was tested by immunoprecipitation after labeling 
with [35S]methionine. No immunoreactive protein was de- 
tected in the supernatant with either mAb 5B1 (Reist et 
al., 1987; data not shown) or a polyclonal antiserum raised 
against the 95 kD, COOH-terminal fragment of chick 
agrin (Gesemann et al., 1995; Fig. 2), indicating that cFull ps 
is not secreted from COS-7 cells. No agrin-like immunore- 
activity, as assayed by immunohistochemistry, was found 
associated with the cell surface of transfected COS cells 
(data not shown). 
Soluble secretory molecules usually contain a signal se- 
quence located at their NH2 terminus that targets protein 
synthesis to the endoplasmatic reticulum (for review see 
Verner and Schatz, 1988). Such sequences are character- 
ized by a stretch of 16-26 residues with a polar, basic NH2 
terminus and a central hydrophobic ore of 7-15 residues 
(von Heijne, 1983; Perlman and Halvarson, 1983). Be- 
cause the NH2-terminal sequence of the cDNA of Tsim et 
al. (1992) does not meet these criteria, we replaced it with 
the signal sequence of hemagglutinin. The latter sequence 
is capable of targeting protein synthesis of agrin fragments 
to the secretory pathway (Tsim et al., 1992; Ruegg et al., 
1992; Gesemann et al., 1995). As shown in Fig. 2, cFull hs 
(for chick full-length with emagglutinin signal sequence; 
Fig. 1) accumulates in the medium of transfected cells. As 
reported previously (Gesemann et al., 1995), it has an ap- 
Figure 2. Recombinant agrin 
is secreted from COS cells af- 
ter replacement of the puta- 
tive signal sequence by the 
signal sequence of hemagglu- 
tinin. COS-7 cells were trans- 
fected with cDNA described 
by Tsim et al. (1992), encod- 
ing full-length agrin (cFull ps) 
or with cDNA construct 
where the first 38 amino ac- 
ids at the NH2-terminus had 
been replaced by the signal 
sequence of hemagglutinin 
(cFullhS). A mock transfection 
(Mock) provided a control. 
Conditioned medium from 
[35S]methionine labeled COS 
cells was immunoprecipitated 
with anti-agrin antiserum, an- 
alyzed on 3-12% SDS-PAGE, 
and proteins were visualized 
by fluorography. No agrin- 
like protein is detected with 
cFull ps while cFull hs is effi- 
ciently secreted into the me- 
dium. As reported previously 
(Gesemann et al., 1995), its 
apparent molecular mass is more than 400 kD, indicating the 
high content of carbohydrates. Molecular weights in kD of stan- 
dard proteins are indicated. 
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Figure 3. 5' Sequences of 
chick agrin mRNA. The 
cDNA sequence shown is the
result of RACE experiments 
and analysis of the chick 
agrin gene. The sequence not 
described in Tsim et al., 
(1992) starts upstream of nu- 
cleotide 368 (*). An addi- 
tional thymidine that neu- 
tralizes the in-frame stop 
codon is located at nucle- 
otide position 419 (I'). The 
shaded area depicts the ex- 
tended NH2-terminal se- 
quence. The new start codon 
at nucleotide position 91 is 
part of a consensus sequence 
for initiation of translation 
(Kozak, 1986) and is fol- 
lowed by 23 mainly hydrophobic residues and the proposed signal sequence cleavage site at Asn 25 (circle; von Heijne, 1986). Position 
and names of primers used for RACE experiments and RT-PCR are shown. The formerly proposed initiator methionine at mino acid 
position 119 (bold), intron-exon boundaries ($) and a new potential N-glycosylation site at Asn 130 (0) are indicated. Note that the ho- 
mology between chick and rat agrin begins only at Lys 158 (L_.~). These sequence data are available from GenBank/EMBL/DDBJ under 
accession umber U35613. 
parent molecular mass of 400-600 kD on SDS-PAGE. 
This result shows that the NH2-terminal sequence of 
cFull ps does not serve as a signal sequence in COS cells. 
In an attempt to isolate the endogenous signal sequence 
of chick agrin, we performed RACE experiments (£apid 
amplification of cDNA ends; Frohmann et al., 1988; Loh 
et al., 1989) on poly A ÷ RNA from E5 to E6 chick spinal 
cord. Agrin-derived primers as366 used for reverse tran- 
scription, and as232 for the subsequent anchored PCR 
were both designed to anneal at the 5' end of the agrin 
mRNA where chick and rat agrin are still highly homolo- 
gous (see Fig. 3). We analyzed more thah 40 individual 
PCR products. The longest PCR product comprised se- 
quences from position 107 through 620 (Fig. 3). In all the 
clones analyzed, an additional thymidine residue was in- 
serted at position 419 (T, Fig. 3). This insertion neutralizes 
the in-frame stop codon upstream of the initiator methio- 
nine' postulated by Tsim et al. (1992) and extends the open 
reading frame. The 5' end of the longest PCR product 
coded for a stretch of hydrophobic amino acids indicative 
of a signal sequence (von Heijne, 1983; Perlman and Hal- 
varson, 1983), but no new initiator methionine was found. 
Several attempts with altered conditions did not yield 
longer RACE products (data not shown). One reason may 
be that the secondary structure of agrin mRNA induced a 
premature stop of reverse transcription (Sambrook et al., 
1989). 
We therefore screened a chick genomic library with a 
DNA probe spanning nucleotides 134 to 547 (for the loca- 
tion see Fig. 3). Out of 9 X 105 phages creened, two posi- 
tive clones were analyzed. In both clones, an in-frame 
ATG was found 16 nucleotides upstream of the longest 
PCR product. This ATG is part of a consensus for initia- 
tion of translation in eukaryotes (Kozak, 1986) and is fol- 
lowed by 24 mainly hydrophobic amino acids that may 
serve as the signal sequence (von Heijne, 1986). In addi- 
tion, an in-frame stop codon is located 63 nucleotides up- 
stream of the potential site of initiation. To prove that these 
novel sequences are within the transcribed portion of the 
agrin gene, we performed a reverse transcriptase-poly- 
merase chain reaction (RT-PCR). Amplification was con- 
ducted using primers -368 and as-273 (see Fig. 3). Although 
the yield was very low, the resulting PCR product had the 
expected size and could be re-amplified using the primer 
s-368 and a nested primer (data not shown). 
Recombinant Agrin with the Extension Is Secreted 
To generate a cDNA construct that covers the entire cod- 
ing sequence of chick agrin, RT-PCR was performed with 
the sense oligonucleotide EcoRI_s-289, spanning the puta- 
tive initiator methionine, and the antisense oligonucleo- 
tide as232 (see Fig. 3). The PCR product was then fused 
to the cDNA encoding cFull ps. The recombinant protein 
encoded by this construct was called cAgrin (Fig. 1). To 
show that cAgrin was targeted to the secretory pathway of 
COS cells, we investigated the endo-13-N-acetylglucosamini- 
dase (endo H) sensitivity of freshly synthesized protein. 
Endo H removes N-linked carbohydrates that become at- 
tached to the protein backbone in the ER. A decrease of 
the apparent molecular mass upon endo H treatment indi- 
cates that the protein is targeted to the ER. To see this 
shift more clearly, we transfected COS cells with cDNA 
constructs encoding only the NH2-terminal half (termed 
cNAgrin; see Fig. 1), which contains all the potential sites 
for N-linked glycosylation. After a pulse of [35S]methio- 
nine for 30 min, the cells were lysed and agrin-like proteins 
were immunoprecipitated. After incubation with endo H, 
agrin was analyzed on SDS-PAGE. As shown in Fig. 4, the 
construct with the signal sequence of hemagglutinin, 
cNFull hs, is sensitive to endo H, indicating that the pro- 
teins had reached the lumen of the ER where they became 
N-glycosylated. In contrast, cNFull ps is only weakly ex- 
pressed and it is not sensitive to endo H (Fig. 4). The rela- 
tive molecular mass of cNAgrin is also shifted by endo H 
digestion (Fig. 4). These results show that the new NH2- 
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Figure 4. Chick agrin containing the novel NH2-terminal sequence 
is targeted to the endoplasmatic reticulum. COS-7 cells that were 
transiently transfected with cDNA constructs encoding NH2-ter- 
minal agrin fragments (see Fig. 1) were pulsed with [35S]methio- 
nine for 30 min. Recombinant agrin was then isolated from the 
COS cell lysates by immunoprecipitation with anti-agrin antise- 
rum. Immunoprecipitates were incubated in buffer alone ( - )  or 
in the presence of endo H (+) to determine the presence of 
N-linked carbohydrates. Proteins were analyzed on a 4-10% 
SDS-PAGE. The apparent molecular mass of both cNFull hs and 
cNAgrin is decreased upon Endo H treatment, indicating that the 
proteins had reached the lumen of the ER. In contrast, cNFull p~ is 
only weakly expressed and is not sensitive to endo H. The higher 
molecular mass of cNAgrin compared to both, cNFull hs and 
cN-Full p~ is consistent with its 123-amino acid-long extension. 
Molecular weights in kD of standard proteins are shown. 
terminal extension of cAgrin targets biosynthesis to the 
ER. In addition, they demonstrate that agrin encoded by 
the previously proposed full-length chick agrin cDNA is 
not targeted to the ER  confirming that its NHE-terminal 
sequence does not serve as signal sequence. 
Glycosaminoglycan Side Chain Attachment 
Several ines of evidence indicate that agrin is a HSPG: (a) 
Recombinant cFull hs with a calculated molecular mass of 
206 kD, when synthesized by COS-7 and 293 cells, has an 
apparent molecular mass between 400 and 600 kD (Gese- 
mann et al., 1995; Fig. 2 and 7). (b) Cloning of a previously 
characterized major HSPG from chick brain (Halfter, 
1993) has revealed that this HSPG is chick agrin (Tsen et 
al., 1995a). (c) Tryptic peptides derived from a HSPG iso- 
lated from bovine renal tubular basement membranes are 
highly homologous to chick agrin (Hagen et al., 1993; see 
below). 
When we tested the sensitivity of cFull hs to chondroiti- 
nase ABC and keratanase, its molecular weight was not 
decreased (data not shown), while heparitinase treatment 
decreased the apparent molecular mass (Fig. 5). Agrin 
contains at least six potential GAG chain attachment sites 
with the consensus sequence E/DGSGE/D or SGXG 
(Bourdon et al., 1987; Zimmermann and Ruoslahti, 1989). 
Three sites are located in the 95-kD, COOH-terminal part 
of agrin and three sites, whose positions are conserved 
across species, are within the NH2-terminal half (see Fig. 
Figure 5. Heparan sulfate glycosaminoglycan (HS-GAG) chains 
are attached to the NH2-terminal half of chick agrin. COS-7 cells 
were transfected with cDNA constructs encoding the proteins in- 
dicated (see Fig. 1). [35S]Methionine was included for 24 h and af- 
ter immunoprecipitation with anti-agrin antiserum, proteins were 
incubated in the absence ( - )  or presence (+) of heparitinase. 
They were then separated on SDS-PAGE and visualized by fluo- 
rography. Both, cFull hs and cAgrin are sensitive to heparitinase 
and hence carry HS-GAG chains. The NH2-terminal half of 
cFull h~ (lane cNFull h~) is also sensitive to heparitinase, while a 95 
kD, COOH-terminal fragment of agrin (c95) is insensitive, dem- 
onstrating that only the NH2-terminal part of agrin carries 
HS-GAG chains. Molecular weights of standard proteins are 
given in kD. 
1). To see which of these attachment sites in fact carry 
GAG side chains, COS cells were transiently transfected 
with cDNA constructs, encoding cAgrin, cFull hs, and the 
NH2-terminal half (cNFull hs) or the COOH-terminal half 
(c95; see Fig. 1). As expected, incubation with heparitinase 
resulted in the reduction of the apparent molecular mass 
of both cFull hs and cAgrin (Fig. 5). While cNFull hs, the 
NHz-terminal portion of cFull hs, was deglycosylated with 
heparitinase, the COOH-terminal fragment was not sensi- 
tive to the enzyme (Fig. 5). From this we conclude that 
HS-GAG chains are only attached to the NHE-terminal 
portion of agrin. 
Agrin in Tissue Homogenates 
Independent evidence confirms that agrin is a HSPG in 
both mammals and birds. Hagen et al. (1993) isolated a 
HSPG from basement membranes of bovine kidney and 
subsequently determined amino acid sequences of three 
tryptic peptides. As shown in Fig. 6, two peptides are simi- 
lar to both chick and rat agrin. Peptides 2 and 3 are homol- 
ogous to sequences between the first and the second fol- 
listatin (PSTI)-like domain and to sequences preceding 
the first follistatin (PSTI)-like domain of agrin, respec- 
tively. Peptide 1 maps however to the extension presented 
here. These data provide additional evidence that the 
novel sequences described in this report are indeed con- 
tained in mature agrin and that they are conserved be- 
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Figure 6. Amino acids of the novel 5' sequence are conserved be- 
tween chick and bovine agrin. Alignment of three tryptic pep- 
tides (single tter code) of a HSPG from bovine renal tubular 
basement membranes (BTBM; Hagen et al., 1993) with rat and 
chick agrin sequences. Conserved amino acids are shaded. Note 
that peptides 2 and 3 are homologous toboth chick and rat agrin. 
Peptide 1 maps to a region encoded by the novel 5' extension 
(box) and hence is homologous only to chick. The position of the 
initiator methionine of Tsim et al. (1992) isindicated (A). 
tween chick and bovine. The cDNA encoding rat agrin 
(Rupp et al., 1991) is not homologous to chick at its 5' end 
and consequently, it is not homologous to peptide 1 (Fig. 6). 
The calculated molecular mass of the protein backbone 
of chick agrin that includes the extension is 225 kD and 
agrin synthesized by transfected cells has an apparent mo- 
lecular mass of more than 400 kD. However, agrin-like 
proteins purified from basal lamina extracts of different 
tissues and several species appear in two discrete doublets 
with molecular mass of 150/135 and 95/70 kD (Nitkin et 
al., 1987; Godfrey et al., 1988a,b; Godfrey, 1991). Simi- 
larly, Hagen et al. (1993) reported a calculated relative 
molecular mass of the core protein after heparitinase 
treatment of 145 and 125 kD. Hence, agrin seems to be de- 
graded during purification. To examine whether the high 
molecular weight form is found in vivo and to determine 
whether proteolytic fragments of the reported size are also 
detected in freshly homogenized tissue, we performed 
Western blot analyses. To prevent proteolytic degrada- 
tion, tissues were homogenized on ice in the presence of 
several protease inhibitors. Tissues examined were embry- 
onic day 14 (E14) brain (Fig. 7, lanes B), spinal cord (Fig. 
7, lanes S), hindlimb muscle (Fig. 7, lanes M), El0 vitreous 
humor (Fig. 7, lanes V), and E15 liver (Fig. 7, lanes L). 
Conditioned medium of 293 cells that had been stably 
transfected with cDNA encoding cFull h~ provided a posi- 
tive control (Fig. 7, lanes C). Agrin-like proteins were de- 
tected with antisera raised either against the 95 kD, 
COOH-terminal part of agrin (Fig. 7 A), or against cFull h~ 
(Fig. 7 B). No immunoreactivity was observed with the 
corresponding preimmune sera (data not shown) except in 
the vitreous humor where the preimmune serum of the 
anti-c95 antiserum recognized two distinct bands of ~100 
and 125 kD (* in Fig. 7 A, lane V). Agrin-like immunore- 
activity was associated with a high molecular weight band 
in all tissues examined except liver (Fig. 7). The high mo- 
lecular weight agrin was most abundant in the vitreous hu- 
mor, followed by brain, muscle and spinal cord. It was seen 
more clearly with antibodies raised against cFull h~ that car- 
ries HS-GAG chains (Fig. 7 B). Since this band was also 
detected with antibodies against c95 (Fig. 7 A), we con- 
clude that the antigen recognized by anti-cFull hs antibod- 
Figure 7. Agrin in vivo is a high molecular weight protein of 400-- 
600 kD. Western blot analysis of different tissue homogenates us- 
ing either antiserum raised against the 95 kD, COOH-terminal 
half of agrin (A) or cFull hs (B). Samples correspond to: condi- 
tioned medium of 293 cells stably transfected with cDNA encod- 
ing cFull hs (lane C), El4 brain (lane B), El4 and El5 spinal cord 
(lane S), El4 hindlimb muscle (lane M), vitreous humor of El0 
eyes (lane V), and E15 liver (lane L). No immunoreactive pro- 
teins were detected with the preimmune sera, except in vitreous 
humor, where the anti-c95 preimmune serum recognized two 
protein bands (* in A, lane V). Except in liver, agrin-like immu- 
noreactivity in the high molecular weight range is detected in all 
the tissues examined, suggesting that agrin in vivo is also a pro- 
teoglycan. Note that immunoreactive proteins of smaller size are 
present in most tissues examined. Arrows in lane V indicate 
agrin-like proteins that have similar molecular mass as agrin frag- 
ments purified from Torpedo californica (see Nitkin et al., 1987). 
ies is agrin. With both antisera, several fragments were 
seen in most tissues. The detected fragments were some- 
times of different size, which may be due to the divergent 
specificities of the antisera. In liver, only the anti-c95 anti- 
bodies recognized a single band with a relative molecular 
mass of ~125 kD (Fig. 7 A, lane L). We have not charac- 
terized this immunoreactive protein further. However, a 
similar band has been observed in adult rat liver using an 
antiserum raised against a fusion protein encoding se- 
quences just upstream of the 95-kD fragment (Rupp et al., 
1991). The distribution into doublets of 150/135 and 95/70 
kD as observed by others (Nitkin et al., 1987; Godfrey et 
al., 1988a,b; Godfrey, 1991) was not seen consistently in all 
the tissues. Immunoreactive protein bands of ~150 and 90 
kD were evident only in the vitreous humor (arrows in 
lanes V). At embryonic day 10, proteins ecreted from ret- 
inal cells accumulate in this body fluid (e.g., Ruegg et al., 
1989; Halfter, 1993). The presence of both high molecular 
weight band and agrin fragments therefore suggests that a 
fraction of agrin can be proteolyticaUy processed in vivo. 
Alternative Splicing of Agrin mRNA at a Novel Site 
In our RACE experiments on mRNA isolated from E5 to 
E6 chick spinal cord, we obtained two populations of PCR 
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Figure 8. Tissue distribution of the new splice variant. (A) Nucle- 
otide and educed amino acid sequence of cDNAs around the 
novel splice site. Numbering is according to Fig. 3. (B) Autora- 
diogram of PCR products derived from randomly reverse tran- 
scribed mRNA of E5-E6 chick spinal cord (spinal cord) and of 
cultured chick myotubes (muscle). PCR was performed using oli- 
gonucleotides flanking the novel splice site. Control PCR using 
no template (1), cDNA with 21 bp (2), cDNA without 21 bp (3), 
or a mixture of both cDNAs (4). Motor neurons of total spinal 
cord (T) were enriched by panning spinal cord cells with mAb 
SC1 (S), by fractionating them on a metrizamide gradient (M), or 
by the combination of both methods (S÷M). The last column 
(muscle) depicts PCR products from chick myotubes grown in 
culture. (C) Quantification of the relative abundance of agrin 
mRNA including or lacking the 21-bp insert. For each lane 32p. 
counts were measured with a Phosphorlmager and the relative 
abundance of each PCR product was determined. Values are 
means - SEM (n = 3). In E5/E6 spinal cord 82% of agrin mRNA 
includes the 21-bp insert (gray) and 18% lacks it. In muscle cells 
(lane muscle) the ratio between the two transcripts i  reversed 
(19% + 21 bp; 81% - 21 bp). After enrichment for motor neu- 
rons by SC1 panning (lane S), metrizamide gradient centrifuga- 
tion (lane M) and a combination of both procedures (lane S+M) 
the amount of mRNA including the 21 bp is increased to 97%, 
suggesting that motor neurons express pecifically this agrin tran- 
script. 
products that differed by a 21-bp-long insert (Fig. 8 A). 
The peptide EHRKLLA encoded by the insert is not ho- 
mologous to sequences in the database. Its position is close 
to the site where the homology between the chick and rat 
agrin cDNAs ends (see also Fig. 3). Our analysis of the 5' 
end region of the chick agrin gene showed that this 21-bp 
insert is preceded by an intron of at least 2 kb (data not 
shown; see Fig. 3 for intron-exon boundaries). Since both 
genomic clones did not contain sequences further down- 
stream of the 21-bp insert, we do not know whether it is 
encoded by a separate xon. Since such large introns also 
have been seen in the 5' region of the mouse agrin gene 
(Rupp et al., 1992) this feature appears to be conserved. 
Alternative mRNA splicing at the previously character- 
ized sites A and B differs between motor neurons and 
muscle cells (Tsim et al., 1992; Ruegg et al., 1992; McMa- 
han et al., 1992; Thomas et al., 1993; Hoch et al., 1993; 
Smith and O'Dowd, 1994; Ma et al., 1995). To investigate 
whether splicing at the novel site is also tissue dependent, 
we performed RT-PCR on mRNA isolated from E12 
chick hindlimb muscle, cultured myotubes, and cell frac- 
tions from E5 (stages 26 and 27; Hamburger and Hamil- 
ton, 1951) chick spinal cord. The majority of mRNA ex- 
pressed in spinal cord contains the 21-bp insert (Fig. 8, B 
and C, spinal cord, lane T), while conversely, muscle cells 
synthesize mainly mRNA lacking this insert (Fig. 8 B and 
C, muscle). Since we were interested in the distribution of 
the splice variants in motor neurons, we either panned 
freshly dissociated spinal cord cells on petri dishes that 
had been coated with mAb SC1, which recognizes an anti- 
gen expressed by motor neurons and floor plate cells 
(Tanaka and Obata, 1984; Bloch-Gallego et al., 1991), or 
separated them from other cells according to their size on 
a metrizamide gradient (Dohrmann et al., 1986). Finally, 
both methods were applied sequentially to eliminate 
small, SCl-positive cells (Tanaka and Obata, 1984). With 
each enrichment the relative content of agrin mRNA con- 
taining the 21-bp insert increased (Fig. 8, B and C, spinal 
cord, compare lanes T through S+M). In the cell fraction 
with the highest content in large, SCl-positive motor neu- 
rons (lane S+M) 97% of the agrin mRNA contained the 
21 bp (Fig. 8 C). As an independent control for the enrich- 
ment, we also determined the relative amount of agrin 
mRNA containing inserts at site B (data not shown). The 
relative abundance of individual splice variants for site B 
was similar to that reported by Smith and O'Dowd (1994) 
for single ciliary ganglia neurons and obtained earlier with 
the same preparation (McMahan et al., 1992; Honig, L. S., 
M. J. Werle, S. E. I-Iorton, and M. A. Ruegg, manuscript in 
preparation). In summary, we conclude that splicing of 
agrin mRNA at the novel site is regulated. While motor 
neurons express agrin mRNA with the 21-bp insert, mus- 
cle cells ynthesize mainly agrin mRNA lacking this insert. 
Binding of Recombinant Agrin to Extracellular Matrix 
Requires the NH2-terminal Extension 
Agrin was originally purified from basal lamina extracts of 
the electric organ of Torpedo californica (Nitkin et al., 1987). 
Moreover, agrin-like immunoreactivity remains associated 
with synaptic basal lamina for at least three weeks after 
degeneration of the cells at the NMJ (Reist et al., 1987). 
The Journal of Cell Biology, Volume 131, 1995 1554 
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 15, 1995
Figure 9. Binding of recombinant agrin to extracellular matrix requires the NH2-terminal extension. D uble immunofluorescence stain- 
ing of transiently transfected COS-7 cells grown on Matrigel TM. The constructs and agrin isoforms used are indicated on the left of each 
row (see Fig. 1 for structure of the constructs). Extracellular grin (nonpermeabilized) was visualized by incubating COS cells with anti- 
bodies directed against the 95 kD, COOH-terminal fragment at 4°C for 30 min and an appropriate, fluorescein-conjugated secondary 
antibody. To identify transfected cells, cells were p rmeabilized and agrin was subsequently visualized with mAb 5B1 and a rhodamine- 
conjugated secondary antibody (permeabilized). Nodeposition of agrin in Matrigel TM is observed with C95AaB8 and cFullh~A4B8 (A and B), 
while agrin is deposited ina gradient with both constructs that include the extension, cAgrinoAaBs and cAgrinTA4B 8 (C and D). Bar, 40 I~m. 
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Hence, in addition to inducing AChR aggregates, agrin 
also must bind to basal amina (McMahan, 1990). To local- 
ize the region in agrin that confers its binding to ECM and 
to test whether alternative mRNA splicing affects the bind- 
ing, transiently transfected COS cells were grown over- 
night on MatrigeF M,a solubilized basement membrane ex- 
tracted from the Engelbreth-Holm-Swarm (EHS) mouse 
sarcoma (Kleinman et al., 1982). Deposition of agrin iso- 
forms was assayed by extracellular staining with antibod- 
ies directed against he 95-kD COOH-terminal fragment 
of agrin. COS cells were then permeabilized and stained 
with mAb 5B1 (Reist et al., 1987) to identify transfected 
cells. No deposits in Matrigel TM are detected with cells that 
express the 95-kD COOH-terminal fragment of agrinA4B8 
(Fig. 9 A) although intracellular staining shows that C95A4B8 
is synthesized (Fig. 9 A'). The cDNA construct encoding 
recombinant agrin, eFullbSA4B8, that does not include the 5' 
extension shows the same staining pattern as C95A4B8 (Fig. 
9, B and B'). In contrast, cAgrinTA4BS, a splice variant hat 
includes the 7-amino acid insert at the new site, is effi- 
ciently deposited in the MatrigeF M predominantly in the 
vicinity of transfected COS cells (Fig. 9 C). Exclusion of 
the 7-amino acid insert at the new site did not change the 
staining pattern on Matrigel TM (Fig. 9 D, but see below). 
Similarly, no effect of splicing at sites A and B was ob- 
served (data not shown). No staining was observed on the 
cell surface of COS cells. This contrasts results by Cam- 
panelli et al. (1991) where full-length rat agrin remained 
associated with the cell surface. The close association of 
the COS cells with MatrigeF M also prevented anti-agrin 
antibodies from staining extracellular agrin at the basal 
site of the transfected cell. After permeabilization, the 
staining with mAb 5B1 was much stronger when COS cells 
had been transfected with constructs including the exten- 
sion than with cDNAs lacking it (compare Fig. 9, A' and 
B' with C' and D'), suggesting that agrin was also de- 
posited on the basal site of the COS cells. The deposition 
of recombinant agrin was not seen on uncoated or gelatin- 
coated tissue culture dishes (data not shown), indicating 
that the binding occurs to specific components of the 
Matrigel TM. 
To quantify the binding of recombinant agrin to Matri- 
gel TM and to see whether alternative splicing at the novel 
site may influence this binding, we next compared the con- 
centration of recombinant protein in the conditioned me- 
dium of transiently transfected COS cells that were ither 
grown on normal tissue culture dishes or on Matrigel TM- 
coated dishes. As shown in Table I, no significant differ- 
ence in the concentration of recombinant agrin on either 
substrate was seen with C95A4BS and cFullbSA4B8 . In con- 
trast, the concentration of recombinant agrin that re- 
mained soluble on MatrigelXM-coated ishes was less than 
50% with both constructs that include the 5' extension. 
Moreover, in two independent experiments, considerably 
more cAgrin0A4B8 was bound to Matrigel TM than cAgrinTAaB s.
Hence, alternative splicing at the novel site may influence 
binding of agrin to extracellular matrix. 
The NHz-terminal Extension Influences Size But Not 
Extent of Agrin-induced A ChR Clusters 
AChR-aggregating activity of agrin is strongly regulated 
Table I. Relative Concentration of Recombinant Agrin in the 
Medium of Transiently Transfected COS Cells Plated on 
MatrigelrM-coated Dishes 
Protein Plastic Matrigel 
mean +- SEM mean -+ SEM 
C95A4/38 100.0 ----- 3.4 99.2 --+ 3.2 
cFulI~SA4B8 100.0 --+ 4.8 100.7 _+ 2.4 
cAgrin7A4B8 100.0 ± 1.7 45.2 --+ 1.2 
cAgrin0A4a8 100.0 ± 3.4 22.3 ___ 1.8 
COS cells were transfected with cDNAs encoding the indicated agrin constructs. One 
day after transfection, cells were replated in the same density on regular tissue culture 
dishes (plastic) or on MatrigelTM-coated dishes (Matrigel). After l 8 h, conditioned me- 
dium was collected and the concentration f recombinant agrin was determined by 
ELISA as described in Materials and Methods. Concentration of agrin with cells 
grown on regular tissue culture dishes was set as 100%. Values are means -+ SEM of 
two independent experiments with triplicate cultures for each condition. The concen- 
tration of C95A4B8 and cFulIhSA~B8 and cFulIhSAaB8 does not change, indicating that hese 
constructs do not bind to Matrigel TM. In contrast, both cAgrin7AaB 8 and cAgrin0A4B8 
bind to Matrigel TM. Note also the difference in binding to Matrigel TM between agrin 
constructs with different inserts at the novel splice site. 
by the alternatively spliced inserts A and B (Ruegg et al., 
1992; Ferns et al., 1992, 1993; Gesemann et al., 1995). The 
dependence of activity on these inserts was observed with 
95-kD COOH-terminal fragments and those that included 
the NH2-terminal part of agrin (cFullbs; Gesemann et al., 
1995). To test whether recombinant grin isoforms with 
the extension were also active in AChR aggregation i an 
isoform-specific manner we incubated cultured chick myo- 
tubes for 16 h with an excess of recombinant protein. 
AChRs were visualized using rhodamine-labeled a-bunga- 
rotoxin. No AChR clustering was detected after incuba- 
tion with conditioned medium of mock-transfected cells 
(Fig. 10 A). Agrin isoforms that lacked the A and the B in- 
serts also did not induce receptor clustering (cFullhSAoB0, 
Fig. 10 C; cAgrinTAOB0, Fig. 10 E; cAgrin0AOB0, Fig. 10 G). 
As shown previously, clustering of AChRs was clearly in- 
duced by 500 pM of C95A4BS (Fig. 10 B) and cFullhSA4B8 
(Fig. 10 D). Agrin isoforms that included the extension 
were also activ~ in inducing AChR clusters (cAgrin7AaBS, 
Fig. 10 F; cAgrin0AaBS, Fig. 10 H). AChR clusters induced 
by these constructs were however smaller and more fre- 
quent (Fig. 10, F and H) than those induced by agrin frag- 
ments (Fig 10, B and D). The average size of AChR clus- 
ters induced by cFullh~A4B s in 20 myotube segments was 
26.2 _+ 2.3 p,m 2 (mean __+ SEM), while induction by 
cAgrin7A4BS yielded clusters with an average size of 10.8 --- 
0.6 ixm 2 (mean __- SEM). To determine whether the change 
in size was based on decreased AChR-aggregating activity, 
we measured the area of AChR clusters with a computer- 
ized image analysis system. As shown in Fig. 10 I, there 
was no significant difference between active agrin iso- 
forms that have the extension and their corresponding 
fragments. The distribution of AChR clusters (aligned ver- 
sus dispersed; compare Fig. 10, F and H) sometimes varied 
between cAgrinTAaB8 and cAgrin0AaB8. However, we could 
not reproduce this phenomenon consistently. In summary, 
these results how that AChR-aggregating activity of com- 
plete chick agrin depends on splice inserts at sites A and B 
and that the most NH2-terminal sequence of agrin alters 
the size of the induced clusters but not he overall extent 
of the induction. 
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Figure 10. Agrin with the NH2-terminal extension induces smaller 
AChR clusters. Fluorescence micrographs ofcultured chick myo- 
tubes labeled with rhodamine-a-bungarotoxin. Myotubes wer  
incubated for 16 h with conditioned medium of COS cells, that 
had been mock-transfected (A) or with cDNAs encoding C95A4BS 
(B), cFullhSAoB0 (C), cFullhSA4B8 (D), cAgrin7n0B 0 (E), cAgrin7A4B 8 
(F), cAgrin0g0B0 (G) and cAgrin0a4Bs (H). The concentration f
recombinant agrin was always 500 pM. Only agrinn4B8 isoforms 
induced AChR aggregates (B, D, F, and H), whereas agring0ao 
isoforms were inactive (C, E, and G). Active agrin including the 
extension (cAgrin7ggBs, F; cAgrin0A4BS, H) induced smaller clus- 
ters. Bar, 50 ~m. (/) Quantification of AChR aggregation. Due to 
the smaller size of AChR clusters induced by active agrin iso- 
forms that include the extension AChR aggregates with t e 
longer axis/>2 p.m are included. Activity is expressed as percent- 
age area of AChR clusters. Each data point represents mean _+ 
SEM of duplicate cultures, where 10 myotube segments were 
counted in each. The control corresponds tomyotubes incubated 
with conditioned medium of mock-transfected COS cells. Results 
of one representative experiment are shown. 
Discussion 
Differences between Chick and Rat Agrin 
We report here the heterologous expression of chick agrin 
comprising all the functional properties that have been 
postulated for endogenous agrin (McMahan, 1990). This 
was achieved by ligating the novel 5' end sequences to the 
cDNAs described by Tsim et al. (1992). When grown on 
noncoated tissue culture dishes, two different cell lines 
transfected with this construct secrete the recombinant 
protein into the medium (Figs. 5 and 7), This contrasts the 
results of Campanelli et al. (1991) where recombinant full- 
length rat agrin remained associated with the cell surface 
of transfected COS and CHO cells. Comparison of the 
protein sequences of chick and rat agrin suggests that the 
difference resides in the NH2 terminus. Although chick 
and rat agrin are highly conserved (60% identity), no ho- 
mology is found in the previously postulated putative sig- 
nal peptides (Rupp et al., 1991; Tsim et al., 1992). The 
80% identity of the 15-amino acid peptide of bovine kid- 
ney HSPG with a corresponding stretch in the 5' extended 
region in chick (Fig. 6) shows that the formerly postulated 
signal sequence of chick agrin is in fact part of the mature 
protein, This, together with our finding that the extension 
is important for the binding of agrin to ECM, makes it very 
likely that rat agrin also contains ahomologous stretch. The 
published NH2-terminal sequence of rat agrin (Rupp et al., 
1991) is however completely different to our extension 
and to the bovine peptide and may therefore be derived 
from a rat agrin mRNA that encodes an alternative 5' se- 
quence. 
The calculated relative molecular mass of chick agrin is 
225 kD. When expressed in COS and 293 cells, recombi- 
nant chick agrin has a relative molecular mass of 400 to 
600 kD (Fig. 5) due to the attachment of carbohydrates. 
Similarly, agrin-like immunoreactivity in tissue homoge- 
nares has the same apparent molecular mass (Tsen et al., 
1995a; Fig. 7). Full-length rat agrin expressed by COS cells 
and agrin-like protein in rat tissue homogenates has how- 
ever an apparent molecular mass of ~200 kD (Rupp et al., 
1991; Campanelli et al., 1991). In addition, ray and chick 
agrin-like proteins in earlier studies appear as distinct pro- 
tein bands between 150 and 70 kD (Nitkin et al., 1987; 
Godfrey et al., 1988a,b; Godfrey, 1991). The difference in 
the molecular mass observed earlier and our results sug- 
gests that the previously described immunoreactive pro- 
teins result from degradation. Although we observed sev- 
eral smaller protein bands in our Western blots, the 
presence of agrin-like protein at a high molecular mass in-
dicates that agrin in vivo can be released from cells with- 
out proteolytic processing. One possible explanation for 
the absence of the high molecular mass bands in earlier 
studies may be that the antibodies used were directed ei- 
ther against he nonglycosylated, COOH-terminal part of 
agrin or against fusion proteins expressed in Escherichia 
coll. As shown in Fig. 7, such antibodies have a lower avid- 
ity for the highly glycosylated agrin. 
Possible Role of Agrin as a Heparan 
Sulfate Proteoglycan 
We show here that sites within the NH2-terminal half of 
agrin carry N-linked carbohydrates and HS-GAG side 
chains (Figs. 4 and 5), and that the COOH-terminal end 
lacks these glycosylations. The attachment of GAG side 
chains is not necessary for agrin's activity to induce AChR 
clusters (Gesemann et al., 1995). Several ines of evidence 
suggest however that HSPGs expressed by the muscle cells 
Denzer et al. Full-length Chick Agrin 1557 
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 15, 1995
do play a role (Wallace, 1991; Ferns et al., 1992, 1993; Gor- 
don et al., 1993). We have therefore recently postulated 
that agrin may bind to HSPGs expressed in muscle cells 
and that these HSPGs may help to present agrin to its pos- 
tulated signal-transducing receptor (Gesemann et al., 
1995). Because agrin expressed by muscle cells is a HSPG 
(Fig. 7) and because it accumulates at AChR clusters 
(Lieth et al., 1992), muscle agrin itself may be such a helper 
protein. Indeed, the 95-kD fragment of the active isoform 
agrinAaB8 binds weakly to the longer, inactive r combinant 
cFullhSAoB0 that carries HS-GAG chains (Gesemann, M., 
A. J. Denzer, and M. A. Ruegg, unpublished observation). 
Agrin's role as a HSPG may be similar to those de- 
scribed for other HSPGs. They are believed to play a role 
in the scaffold for the attachment of various ECM compo- 
nents and to modulate interactions with cells during mor- 
phogenesis (for a review see Timpl, 1993). The presence of 
HS-GAG chains together with a similar arrangement of
structural motifs makes agrin a homologue to perlecan 
(Noonan et al., 1991). Perlecan is a low affinity, auxiliary 
receptor for basic fibroblast growth factor, a potent 
growth factor involved in angiogenesis, and this interac- 
tion is dependent on its HS-GAG chains (Aviezer et al., 
1995). Since agrin is highly expressed uring the develop- 
ment of the nervous system (McMahan et al., 1992; 
O'Connor et al., 1994; Ma et al., 1994), it may have func- 
tions similar to those described for perlecan (reviewed in 
Iozzo et al., 1994). Recent evidence suggests that agrin, 
which is also expressed in axonal tracts of the developing 
chick visual system (Halfter, 1993), modulates the ho- 
mophilic binding of the cell adhesion molecule N-CAM. 
This function depends on the presence of HS-GAG chains 
in agrin and hence is constricted to its NH2-terminal half 
(Burg et al., 1995). 
Binding of Agrin to Extracellular Matrix and 
A ChR-aggregating Activity 
We show that binding of agrin to ECM, detected as a dep- 
osition in Matrigel TM, requires the novel NH2-terminal se- 
quence (Fig. 9). This preparation of solubilized basement 
membrane contains mainly laminin-1 (EHS laminin), col- 
lagen IV, HSPGs, and nidogen (Kleinman et al., 1982). 
Hence, any of these proteins may be a binding partner for 
agrin. Deposition of agrin-like immunoreactivity on a sim- 
ilar substrate has also been observed with spinal cord neu- 
rons of Xenopus laevis (Cohen et al., 1994), supporting our 
conclusion that the construct we describe here codes for 
the entire chick agrin. 
AChR aggregates induced by this construct are smaller 
than those induced by agrin fragments. Small AChR ag- 
gregates (<4 p~m 2) are formed within two hours when 
agrin isolated from Torpedo californica is added to me- 
dium bathing chick myotubes. Their size increases with 
time and reaches a maximum after 16 to 20 h (Wallace, 
1988). This increase in size is, at least in part, based on the 
fusion of the small aggregates (Wallace, 1994). It is con- 
ceivable that Torpedo agrin bound to its postulated signal- 
transducing receptor is still mobile in the muscle cell mem- 
brane. Therefore, small clusters can merge to form bigger 
clusters. Because the partially purified agrin from Torpedo 
californica used in these studies contains mainly COOH- 
terminal fragments (Nitkin et al., 1987), it does not bind to 
ECM. We propose that recombinant agrin including the 
extension, which additionally binds to ECM, immobilizes 
the small clusters and prevents them from erging, or, al- 
ternatively, prolongs the time needed for the fusion. 
Alternative mRNA Splicing at the Novel Site 
Is Regulated 
We also describe a site of 21-bp length that undergoes al- 
ternative mRNA splicing. As reported for sites A and B, 
the splice variants are expressed ifferentially by presyn- 
aptic motor neurons and postsynaptic muscle cells (Fig. 8). 
As embryonic day 5 to 6 motor neurons (HH stage 26 and 
27; Hamburger and Hamilton, 1951) extend their axons to 
muscle, AChRs begin to cluster in response to these in- 
growing axons (Dahm and Landmesser, 1991). This is also 
the time when motor neurons express high levels of SC1 
(also known as DM-GRASP or BEN; Pourquie et al., 
1990; Burns et al., 1991). In the purest preparation of mo- 
tor neurons, 97% of agrin mRNA contains the 21-bp in- 
sert. In this cell fraction more than 95 % are motor neurons 
(Bloch-Gallego et al., 1991). Hence, the 3% of agrin 
mRNA lacking the 21-bp insert most likely represents 
contamination by nonmotor neurons and we conclude 
that, early in synaptogenesis, chick motor neurons ynthe- 
size agrin mRNA that contains the 21-bp insert. On the 
other hand, in postsynaptic cells, such as El2 (HH stage 
38; Hamburger and Hamilton, 1951) hindlimb muscle and 
myotubes grown in culture, the majority of agrin mRNA 
lacks the 21-bp insert. El0 dorsal root ganglia also synthe- 
size predominantly agrin mRNA containing the 21-bp in- 
sert and Schwann cells of the sciatic nerve have a pattern 
similar to muscle cells (Denzer, A. J., and M. A. Ruegg, 
unpublished ata). This uggests that neurons other than 
motor neurons ynthesize agrin mRNA containing the 21 
bp while nonneuronal cells show a preference for the 
splice variant lacking this insert. Indeed, Tsen et al. (1995b) 
have obtained similar results in the central nervous sys- 
tem, suggesting that nonneuronal cells express mainly 
agrin isoforms lacking the 21-bp insert and neurons yn- 
thesize agrin mRNA that contains the 21-bp insert. We 
have not closely looked at functional differences between 
the splice variants. Our finding that the isoforms eem to 
bind to MatrigeV M with different strength (Table I) sug- 
gests that this insert may regulate the interaction f agrin 
with ECM. We are currently aiming at identifying the 
binding partners of agrin in the ECM and studying in de- 
tail whether splicing at the novel site affects binding. 
We thank Drs. W. B. Adams and E. Reinhard for critically reading the 
manuscript; Dr. H Tanaka for providing SC1 hybridoma nd Dr, P. Son- 
deregger for the chick genomic library. 
This work was supported by a grant No, 31-33697.92 of the Swiss Na- 
tional Science Foundation. 
Received for publication 12 June 1995 and in revised form 13 September 
1995. 
References 
Aviezcr, D., D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon. 1994. 
Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth fac- 
tor-receptor binding, mitogenesis, and angiogenesis. Cell. 79:1005-1013. 
Bloch-Gallego, E., M. Huchet, H. El M'Hamdi, F.-K. Xie, H. Tanaka, and C. E. 
Henderson. 1991. Survival in vitro of motor neurons identified or purified by 
The Joumal of Cell Biology, Volume 131, 1995 1558 
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 15, 1995
novel antibody-based methods is selectively enhanced by muscle-derived 
factors. Development. 111:221-232. 
Bourdon, M. A ,  T. Krusius, S. Campbell, N. B. Schwartz, and E. Ruoslahti. 
1987. Identification and synthesis of a recognition signal for the attachment 
of glycosaminoglycans to proteins. Proc. Natl. Acad. Sci. USA. 84:3194-3198. 
Bowe, M. A., and J. R. Fallon. 1995. The role of agrin in synapse formation. 
Ann. Rev. Neurosci. 18:443-462. 
Burg, M. A., W. Halfter, and G. J. Cole. 1995. Analysis of proteoglycan expres- 
sion in developing chicken brain: characterization f a heparan sulfate pro- 
teoglycau that interacts with the neural cell adhesion molecule. J Neurosci. 
Res. 41:49-64. 
Burns, F. R., S. yon Kannen, L. Guy, J. A. Raper, J. Kamholz, and S. Chang. 
1991. DM-GRASP, a novel immunoglobulin superfamily axonal surface pro- 
tein that supports neurite extension. Neuron. 7:209-220. 
Campanelli, J. T., W. Hoch, F. Rupp, T. Kreiner, and R. H. Scheller. 1991, 
Agrin mediates cell contact-induced acetylcholine receptor clustering. Cell. 
67:909-916. 
Cohen, M. W., and E. W. Godfrey. 1992. Early appearance of and neuronal 
contribution to agrin-like molecules at embryonic frog nerve-muscle syn- 
apses formed in culture. J Neurosci. 12:2982-2992. 
Cohen, M. W., F. Moody-Corbett, and E. W. Godfrey. 1994. Neuritic deposi- 
tion of agrin on culture substrate: implications for nerve-muscle synaptogen- 
esis. J. Neurosci. 14:3293-3303. 
Cohen, M. W., C, Jacobson, E, W. Godfrey, K. P. Campbell, and S. Carbonetto. 
1995. Distribution of c~-dystroglycan during embryonic erve-muscle synap- 
togenesis. J. Cell Biol. 129:1093-1101. 
Cullen, B. R. 1987. Use of eukaryotic expression technology in the functional 
analysis of cloned genes. Methods Enzymol. 152:684-704. 
Dahm, L. M., and L. T. Landmesser. 1991. The regulation of synaptogenesis 
during normal development and following activity blockade. J Neurosci. 11: 
238-255. 
Dohrmann, U., D. Edgar, M. Sendtner, and H. Thoenen. 1986. Muscle-derived 
factors that support survival and promote fiber outgrowth from embryonic 
chick spinal motor neurons in culture. Dev. Biol. 118:209-221. 
Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of mono- 
clonal antibodies pecific for human c-myc proto-oncogene product. Mol. 
Cell. Biol. 5:3610--3616. 
Fallon, J. R., and C. E. Gelfman. 1989. Agrin related molecules are concen- 
trated at acetylcholine receptor clusters in normal and aneural developing 
muscle. J Cell Biol. 108:1527-1535. 
Fallon, J. R., and Z. W. Hall. 1994. Building synapses: agrin and dystroglycan 
stick together. Trends Neurosci, 17:469-473. 
Ferns, M., W. Hoch, J. T, Campanetli, F. Rupp, Z. W. Hall, and R. H. Schetler. 
1992. RNA splicing regulates agrin-mediated acetylcholine r ceptor cluster- 
ing activity on cultured myotubes. Neuron. 8:1079-1086. 
Ferns, M., J. T. Campanelli, W. Hoch, R. H. Scheller, and Z. W. Hall. 1993. The 
ability of agrin to cluster AChRs depends on alternative splicing and cell 
surface proteoglycans. Neuron. 11:491-502. 
Frank, E., and G. D. Fischbach. 1979. Early events in neuromuscular junction 
formation in vitro. Induction of acetylcholine receptor clusters in the 
postsynaptic membrane and morphology of newly formed nerve-muscle syn- 
apses. J Cell Biol. 83:143-158. 
Frohmann, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of 
full-length cDNAs from rare transcripts: amplification using a single gene- 
specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA. 85:8998-9002. 
Gesemann, M., A. J. Denzer, and M. A. Ruegg. 1995. Acetylcholine receptor- 
aggregating activity of agrin isoforms and mapping of the active site. J. Cell 
Biol. 128:625-636. 
Gluzman, Y. 198L SV40-transformed simian cells support he replication of 
early SV40 mutants. Cell. 23:175-182. 
Godfrey, E. W. 1991. Comparison of agrin-like proteins from the extracellular 
matrix of chicken kidney and muscle with neural agrin, a synapse organizing 
protein. Exp. Cell Res. 195:99-109. 
Godfrey, E. W., M. E. Dietz, A. L. Morstad, P. A. Wallskog, and D. E. Yorde. 
1988a. Acetylcholine receptor-aggregating proteins are associated with the 
extracellular matrix of many tissues in Torpedo. J. Cell Biol. 106:1263-1272. 
Godfrey, E. W., R. E. Siebenlist, P. A. WaUskog, L. M. Waiters, D. L. Bolender, 
and D. E. Yorde. 1988b. Basal lamina components are concentrated in pre- 
muscle masses and at early acetylcholine receptor clusters in chick embryo 
hindlimb muscles. Dev. Biol. 130:471-486. 
Gordon, H., M. Lupa, D. Bowen, and Z. Hall. 1993. A muscle cell variant defec- 
tive in glycosaminogtycan biosynthesis forms nerve-induced but not sponta- 
neous cluster of the acetylcholine r ceptor and the 43 kD protein. J. Neuro- 
sci. 13:586--595. 
Hagen, S. G., A. F. Michael, and R. J. Butkowski. 1993. Immunochemical and 
biochemical evidence for distinct basement membrane heparan sulfate pro- 
teoglycans. J. Biol. Chem. 268:7261-7269. 
Halfter, W. 1993. A heparan sulfate proteoglycan i developing avian axonal 
tracts. J. Neurosci. 13:2863-2873. 
Hall, Z. W., and J. R. Sanes. 1993. Synaptic structure and development: the 
neuromuscular junction. Cell/Neuron. 72/10:99-121. 
Hamburger, V., and H. Hamilton. 1951. A series of normal stages in the devel- 
opment of the chick embryo. J Morphol. 88:49-92. 
Hoch, W., M. Ferns, J. T. Campanelli, Z. W. Hall, and R. H. ScheUer. 1993. De- 
velopmental regulation of highly active alternatively spliced forms of agrin. 
Neuron. 11:479-490. 
Iozzo, R. V., I. R. Cohen, S. Gr~issel, and A. D. Murdoch. 1994. The biology of 
perlecan: the multifaceted heparan sulfate proteoglycan of basement mem- 
branes and perieellular matrices. J. Biochem. 302:625-639. 
Kleinman, H. K., M. L. McGarvey, L. A. Livatta, P, G. Robey, K. Tryggvason, 
and G. R. Martin. 1982. Isolation and characterization f type IV procol- 
lagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. 
Biochemistry. 21:6188-6193. 
Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator 
codon that modulates translation by eukaryotic ribosomes. Cell. 44:283-292. 
Lieth, E., C. A. Cardasis, and J. R. Fallon. 1992. Muscle-derived agrin in cul- 
tured myotubes: xpression i the basal lamina and at induced acetylcholine 
receptor clusters. Dev. Biol. 149:41-54. 
Lob, E. Y., J. F. Elliot, S. Cwirla, L. L. Lanier, and M. M. Davis. 1989. Poly- 
merase chain reaction with single-sided specificity: analysis of T cell receptor 
chain. Science (Wash. DC). 243:217-220. 
Ma, E., R. Morgan, and E. W. Godfrey. 1994. Distribution of agrin mRNAs in 
the chick embryo nervous ystem. J. Neurosci. 14:2943-2952. 
Ma, E., R. Morgan, and E. W. Godfrey. 1995. Agrin mRNA variants are differ- 
entially regulated in developing chick embryo spinal cord and sensory gan- 
glia. J. Neurobiol. 26:585-597. 
McMahan, U. J. 1990. The agrin hypothesis. In Cold Spring Harbor Symposium 
on Quantitative Biology. Vol. LV. Cold Spring Harbor Laboratory Press, 
Cold Spring Harbor, NY. 407-418. 
McMahan, U. J., S. E. Horton, M. J. Werle, S. L. Honig, S. KrOger, M. A. 
Ruegg, and G. Escher. 1992. Agrin isoforms and their role in synaptogenesis. 
Curt, Opin. Cell Biol. 4:869-874. 
Nitkin, R. M., M. A. Smith, C. Magill, J. R. Fallon, Y.-M. M. Yao, B. G. Wal- 
lace, and U. J. McMahan. 1987. Identification of agrin, a synaptic organizing 
protein from Torpedo electric organ. J. Cell Biol. 105:2471-2478. 
Noonan, D. M., A. Fulle, P. Valente, S. Cai, E. Horigan, M. Sasaki, Y. Yamada, 
and J. R. Hassell. 199.1. The complete sequence of perlecan, a basement 
membrane heparan sulfate proteoglycan, reveals extensive similarity with 
laminin A chain, low density lipoprotein-receptor, and the neural cell adhe- 
sion molecule. J Biol. Chem. 266:22939-22947. 
O'Connor, L. T., J. C. Lauterborn, C. M. Gall, and M. A. Smith. 1994. Localiza- 
tion and alternative splicing of agrin mRNA in adult rat brain: transcripts 
encoding isoforms that aggregate acetylcholine receptors are not restricted 
to cholinergic regions. J Neurosci. 14:1141-1152. 
Patthy, L., and K. Nikolics. 1993. Function of agrin and agrin-related proteins. 
Trends Neurosci. 16:76--81. 
Perlman, D,  and H. O. Halvarson. 1983. A putative signal peptidase recogni- 
tion site and sequence in eukaryotic and prokaryotic signal peptides. Z MoL 
Biol. 167:391-409. 
Pourquie, O., M, Coltey, J. L. Thomas, and N. M. Le Dourain. 1990. A widely 
distributed antigen developmentally regulated in the nervous system. Devel- 
opment. 109:743-752. 
Reist, N. E., C. Magill, and U. J. McMahan. 1987. Agrin-like molecules at syn- 
aptic sites in normal, denervated, and damaged skeletal muscles. J. Cell Biol. 
105:2457-2469. 
Reist, N. E., M. J. Werle, and U. J. McMahan. 1992. Agrin released by motor 
neurons induces the aggregation of acetylcholine r ceptors at neuromuscu- 
lar junctions. Neuron. 8:865-868. 
Ruegg, M. A., E. T. Stoeckli, R. B. Lanz, P. Streit, and P. Sonderegger. 1989. A 
homologue of the axonally secreted protein axonin-1 is an integral mem- 
brane protein of nerve fiber tracts involved in neurite fasciculation. J. Cell 
BioL 109:2363-2378. 
Ruegg, M. A., K. W. K. Tsim, S. E. Horton, S. Kr6ger, G. Escher, E. M, 
Gensch, and U. J. McMahan. 1992. The agrin gene codes for a family of 
basal amina proteins that differ in function and distribution. Neuron. 8:691- 
699. 
Rupp, F., D. G. Payan, C. Magill-Solc, D. M, Cowan, and R. H. Scheller. 1991. 
Structure and expression of a rat agrin. Neuron. 6:811-823. 
Rupp, F., T. Ozcelik, M. Linial, K. Peterson, U. Franke, and R. Scheller. 1992. 
Structure and chromosomal localization of the mammalian agrin gene. J, 
Neurosci. 12:3535-3544. 
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Labo- 
ratory Manual. Cold Spring Harbor Laboratory Press, New York. 
Smith, M. A., C. Magill-Solc, F. Rupp, Y.-M. M. Yao, J. W. Schilling, P. Snow, 
and U. J. MeMahan. 1992. Isolation and characterization f an agrin homo- 
logue in the marine ray. Mol. Cell Neurosci. 3:406-417~ 
Smith, M. A., and D. K. O'Dowd. 1994. Cell-specific regulation of agrin RNA 
splicing in the chick ciliary ganglion. Neuron. 12:795-804. 
Tanaka, H., and K. Obata. 1984. Developmental changes in unique cell surface 
antigens of chick embryo spinal motor neurons and ganglion cells. Dev, Biol. 
106:26-37. 
Thomas, W. S., D. K. O'Dowd, and M. A. Smith. 1993. Developmental expres- 
sion and alternative splicing of chick agrin mRNA. Dev. Biol. 158:523-535. 
Timpl, R. 1993. Proteoglycans of basement membranes. Experientia. 49:417- 
428. 
Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of pro- 
teins from polyaerylamide g ls to nitrocellulose sheets: procedure and some 
applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354. 
Tsen, G., W. Hairier, S. Kr6ger, and G. J. Cole. 1995a. Agrin is a heparan sul- 
fate proteoglycan. J. Biol. Chem. 270:3392-3399. 
Deuzer et al. Full-length Chick Agrin 1559 
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 15, 1995
Tsen, G., A. Napier, W. Halfter, and G. J. Cole. 1995b. Identification of a novel 
alternatively spliced agrin mRNA that is preferentially expressed in non- 
neuronal cells. Z Biol. Chem. 270:15934-15937. 
Tsim, K. W. K., M. A. Ruegg, G. Escher, S. KrOger, and U. J. McMahan. 1992. 
cDNA that encodes active agrin. Neuron. 8:677-689. 
Verner, K., and G. Schatz. 1988. Protein translocation across membranes. Sci- 
ence (Wash. DC). 241:1307-1313. 
von Heijne, G. 1983. Pattern of amino acids near signal cleavage sites. Eur. J. 
Biochem. 133:17-21. 
yon Heijne, G. 1986. A new method for predicting signal sequence cleavage 
sites. Nucleic Acids Res. 14:4683-4690. 
Wallace, B. G. 1988. Regulation of agrin-induced acetylcholine r ceptor aggre- 
gation by Ca 2+ and phorbol ester. J. Cell Biol. 107:267-278. 
Wallace, B. G. 1989. Agrin-induced specializations contain cytoplasmic, mem- 
brane, and extracellular matrix-associated components of the postsynaptic 
apparatus. 3".Neurosci. 9:1294-1302. 
Wallace, B. G. 1994. Staurosporine inhibits agrin-induced acetylcholine recep- 
tor phosphorylation a d aggregation. J. Cell Biol. 125:661-668. 
Wallace, B. G., Z. Qu, and R. L. Huganir. 1991. Agrin induces phosphorylation 
of the nicotinic acetylcholine r ceptor. Neuron. 6:869~878. 
Wessels, H. P., J. P. Beltzer, and M. Spiess. 1991. Analysis of protein topology 
in the endoplasmic reticulum. Methods Cell Biol. 34:287-302. 
Zimmermann, D. R., and E. Ruoslahti. 1989. Multiple domains of the large fi- 
broblast proteoglycan, versican. EMBO Z 8:2975-2981. 
The Journal of Cell Biology, Volume 131, 1995 1560 
 o
n
 January 4, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published December 15, 1995
